EUVIMEDEUVIMED entdecken
Crossref

Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy

Marc Lallemant, Gonzague Jourdain

Future HIV Therapy · 2007

DOI: 10.2217/17469600.1.1.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future HIV Therapy, 2007. Verfasst von Marc Lallemant und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lallemant, M., & Jourdain, G. (2007). Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy. Future HIV Therapy. https://doi.org/10.2217/17469600.1.1.23

Vancouver

Lallemant M, Jourdain G. Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy. Future HIV Therapy. 2007. doi:10.2217/17469600.1.1.23

BibTeX
@article{Lallemant2007,
  author = {Lallemant, Marc and Jourdain, Gonzague},
  title = {Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy},
  journal = {Future HIV Therapy},
  year = {2007},
  doi = {10.2217/17469600.1.1.23}
}
Kostenlos starten →